Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Androgen Antagonists
×
Clear all
Filters
2
NCT04934722
2025-10-01
KEYNOTE-991
Merck Sharp & Dohme LLC
Phase 3
Completed
186 enrolled
14 charts